Feedback
Settings

Settings

1. WO2005040167 - NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES

PermaLink
Publication Number WO/2005/040167
Publication Date 06.05.2005
International Application No. PCT/SE2004/001522
International Filing Date 21.10.2004
IPC
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
471
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/-C07D463/251
02
in which the condensed system contains two hetero rings
10
Spiro-condensed systems
C07D 471/10 (2006.01)
CPC
C07D 471/10
Applicants
  • ASTRAZENECA AB [SE/SE]; S-151 85 Södertälje, SE (AllExceptUS)
  • BLADH, Håkan [SE/SE]; SE (UsOnly)
  • CONNOLLY, Stephen [GB/GB]; GB (UsOnly)
  • DYKE, Hazel Joan [GB/GB]; GB (UsOnly)
  • LISIUS, Annea [SE/SE]; SE (UsOnly)
  • PRICE, Stephen [GB/GB]; GB (UsOnly)
  • SHAMOVSKY, Igor [CA/SE]; SE (UsOnly)
  • VAN DEN HEUVEL, Marco [NL/GB]; GB (UsOnly)
Inventors
  • BLADH, Håkan; SE
  • CONNOLLY, Stephen; GB
  • DYKE, Hazel Joan; GB
  • LISIUS, Annea; SE
  • PRICE, Stephen; GB
  • SHAMOVSKY, Igor; SE
  • VAN DEN HEUVEL, Marco; GB
Agents
  • ASTRAZENECA; Global Intellectual Property S-151 85 Södertälje, SE
Priority Data
0302811-523.10.2003SE
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES
(FR) NOUVEAUX DIAZASPIROALCANES ET LEUR UTILISATION DANS LE TRAITEMENT DE MALADIES INDUITES PAR CCR8
front page image
Abstract
(EN)
The invention provides compounds of general formula. wherein A, B, W, X, Y, Z, D, E, R1 and n are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
(FR)
L'invention concerne des composés représentés par la formule générale (I). Dans cette formule A, B, W, X, Y, Z, D, E, R1 et n sont définis comme dans la description. L'invention concerne également des procédés de préparation de ces composés, des compositions pharmaceutiques les contenant et leur utilisation thérapeutique.
Also published as
AU2004284028
CA2542226
CN1898239
EP1678178
IL174698
IN2803/DELNP/2006
JP2007509141
KR1020060088557
MXPA/a/2006/004300
NO20062335
NZ546585
US20070249648
ZA2006/03174
ZA200603174
Other related publications
AR046600
BRPI0415613
MYPI 20044369
TH88598
UY0001028572
Latest bibliographic data on file with the International Bureau
# -